A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis
Clinical trial NCT03101670 · COMPLETED
Trial details
- NCT number
- NCT03101670
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2018-03-12
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.